Abstract
Juvenile Ossifying Fibroma (JOF) is one of the rarest entities within the very heterogeneous and large group of benign fibro-osseous tumors. It is often diagnosed in the first two decades of life, is usually asymptomatic, and affects males and females equally. JOF commonly arises in the mandibular or maxillary region and has a particularly aggressive behavior, characterized by rapid growth and a high risk of recurrence (estimated at 20-50%). Surgical enucleation, followed by curettage and/or osteotomy remains the mainstay of treatment.